PROAIR RESPICLICK Rx
Generic Name and Formulations:
Albuterol sulfate 90mcg/inh; dry pwd for oral inhalation with a dose counter.
Indications for PROAIR RESPICLICK:
Adults and Children:
<4yrs: not established. ≥4yrs: 2 inh every 4–6hrs; in some patients: 1 inh every 4hrs may suffice. Exercise-induced bronchospasm: 2 inh 15–30 mins before exercise.
Severe hypersensitivity to milk proteins.
Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy. Nursing mothers.
During or within 2 weeks of MAOIs or tricyclics (increased cardiovascular effects); consider alternative therapy. Oral sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with non-potassium sparing diuretics (eg, loop or thiazide); monitor.
Back pain, pain, viral gastroenteritis, sinus headache, urinary tract infection; children: nasopharyngitis, oropharyngeal pain, vomiting; hypokalemia, paradoxical bronchospasm, cardiovascular effects, immediate hypersensitivity reactions (eg, rash, urticaria, angioedema).
Inhaler (w. dose counter)—0.65g (200 inh)
Endocrinology Advisor Articles
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Gender-Related Association Between Physical Activity, Psychological Status in T2D
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Choroidal Thickness Changes in Patients With Untreated Diabetes
- Pre-Pregnancy Fitness Lowers Gestational Diabetes Risk